Research & Development

Rentschler Biopharma Expands cGMP and Cell & Gene Therapy Services
Research & Development Rentschler Biopharma Expands cGMP and Cell & Gene Therapy Services

Rentschler Biopharma, a globally recognized Contract Development and Manufacturing Organization (CDMO), is making significant strides in the biomanufacturing landscape. The company's recent investments showcase its commitment to expanding cGMP capabilities and bolstering cell and gene therapy

Vertex's Suzetrigine Shows Promise as a Non-Opioid Painkiller
Research & Development Vertex's Suzetrigine Shows Promise as a Non-Opioid Painkiller

Vertex Pharmaceuticals is on the brink of introducing suzetrigine, a cutting-edge non-opioid painkiller that has showcased promising results in recent phase 3 clinical trials. As the battle against opioid addiction and abuse intensifies, the advent of suzetrigine brings hope for a safer approach to

Enhancing Clinical Trials: Patient-Centricity and Decentralization Innovations
Research & Development Enhancing Clinical Trials: Patient-Centricity and Decentralization Innovations

Clinical trials have long faced significant challenges in enrolling and retaining participants, a problem exacerbated by logistical and engagement difficulties inherent in the clinical trial process. Recent data highlights that up to one-third of trial participants drop out before the studies are

AI Revolutionizes Early Drug Discovery with Precision and Efficiency
Research & Development AI Revolutionizes Early Drug Discovery with Precision and Efficiency

The modern biopharmaceutical industry is witnessing a significant transformation, thanks to the integration of artificial intelligence (AI) tools in early drug discovery. AI’s capabilities in managing and analyzing vast amounts of data generated from cell-based preclinical models through imaging a

FDA Approves First Targeted Therapy for Advanced Gastric Cancer
Research & Development FDA Approves First Targeted Therapy for Advanced Gastric Cancer

In a significant leap forward for oncology, the U.S. Food and Drug Administration (FDA) has given the green light to Astellas Pharma Inc.'s VYLOY (zolbetuximab-clzb) for treating adults with advanced, unresectable, or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric

How Does the Retrogenix Non-Human Protein Library Aid Drug Discovery?
Research & Development How Does the Retrogenix Non-Human Protein Library Aid Drug Discovery?

Charles River Laboratories has taken a significant stride in the realm of biopharmaceutical research by launching the Retrogenix Non-Human Protein Library. This innovation is particularly designed to help clients assess the off-target interactions of their therapeutics with non-human proteins. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later